Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 4Recruiting 2Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 51Neoplasms 45Colorectal Neoplasms 27Carcinoma, Non-Small-Cell Lung 22Prostatic Neoplasms 20Lung Neoplasms 16Leukemia, Myeloid, Acute 16Recurrence 12Multiple Myeloma 11Melanoma 11Stomach Neoplasms 10Head and Neck Neoplasms 10Ovarian Neoplasms 9Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Pancreatic Neoplasms 7Neoplasm Metastasis 7Myelodysplastic Syndromes 7Lymphoma 7Glioma 7Carcinoma, Renal Cell 7Brain Neoplasms 7Motor Activity 6Leukemia 6Hodgkin Disease 6Esophageal Neoplasms 6Colonic Neoplasms 6Carcinoma, Hepatocellular 6

Interventions

Ritonavir 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Breast Cancer × 30 days × Clear all
NCT06710990 2026-06-04

Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
17 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡